These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 23010303)

  • 1. Hepatocellular carcinoma surveillance: all cirrhotic patients may not be equal.
    Mayorga C; Yopp AC; Singal AG
    Gastroenterology; 2012 Nov; 143(5):1393-1395. PubMed ID: 23010303
    [No Abstract]   [Full Text] [Related]  

  • 2. HGF, MET, and matrix-related proteases in hepatocellular carcinoma, fibrolamellar variant, cirrhotic and normal liver.
    Schoedel KE; Tyner VZ; Kim TH; Michalopoulos GK; Mars WM
    Mod Pathol; 2003 Jan; 16(1):14-21. PubMed ID: 12527708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative metabolism in cirrhotic patients with and without hepatocellular carcinoma: effects of malnutrition.
    Guglielmi FW; Mastronuzzi T; De Marco M; Laddaga L; Panella C; Francavilla A
    Hepatology; 1992 Nov; 16(5):1144-9. PubMed ID: 1330866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Semiannual and annual surveillance of cirrhotic patients for hepatocellular carcinoma: effects on cancer stage and patient survival (Italian experience).
    Trevisani F; De Notariis S; Rapaccini G; Farinati F; Benvegnù L; Zoli M; Grazi GL; Del PP; Di N; Bernardi M;
    Am J Gastroenterol; 2002 Mar; 97(3):734-44. PubMed ID: 11922571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocellular carcinoma in the non-cirrhotic liver: a comparison with that complicating cirrhosis.
    Melia WM; Wilkinson ML; Portmann BC; Johnson PJ; Williams R
    Q J Med; 1984; 53(211):391-400. PubMed ID: 6207557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic changes in ultrasound characteristics of nodules in cirrhotic liver and their implications in surveillance for malignancy.
    Wu S; Tu R; Liu G; Shi Y
    J Med Ultrason (2001); 2014 Apr; 41(2):165-71. PubMed ID: 27277769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surveillance for hepatocellular carcinoma in patients with cirrhosis improves outcome.
    Stravitz RT; Heuman DM; Chand N; Sterling RK; Shiffman ML; Luketic VA; Sanyal AJ; Habib A; Mihas AA; Giles HC; Maluf DG; Cotterell AH; Posner MP; Fisher RA
    Am J Med; 2008 Feb; 121(2):119-26. PubMed ID: 18261500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does surveillance for hepatocellular carcinoma in HCV cirrhotic patients improve treatment outcome mainly due to better clinical status at diagnosis?
    Giannini E; Arzani L; Borro P; Botta F; Fasoli A; Risso D; Celle G; Testa R
    Hepatogastroenterology; 2000; 47(35):1395-8. PubMed ID: 11100360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of hepatocellular carcinoma occurring in a cirrhotic liver--laparoscopically confirmed transition from a cirrhotic nodule to a hepatocellular carcinoma at an interval of 10 months.
    Iwamura K; Hirayama S; Inaba R; Golebiowski M
    Tokai J Exp Clin Med; 1984 Mar; 9(1):69-79. PubMed ID: 6100145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocellular carcinoma in patients without cirrhosis in Italy.
    Giannini EG; Marenco S; Bruzzone L; Savarino V; Farinati F; Del Poggio P; Rapaccini GL; Di Nolfo MA; Benvegnù L; Zoli M; Borzio F; Caturelli E; Chiaramonte M; Trevisani F
    Dig Liver Dis; 2013 Feb; 45(2):164-9. PubMed ID: 23047000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leptin receptor somatic mutations are frequent in HCV-infected cirrhotic liver and associated with hepatocellular carcinoma.
    Ikeda A; Shimizu T; Matsumoto Y; Fujii Y; Eso Y; Inuzuka T; Mizuguchi A; Shimizu K; Hatano E; Uemoto S; Chiba T; Marusawa H
    Gastroenterology; 2014 Jan; 146(1):222-32.e35. PubMed ID: 24055508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of growth hormone receptor mRNA in hepatocellular carcinoma and matched para-cancer cirrhotic liver tissue].
    Wang HT; Wang J; Ou QJ; Liu XP; Chen S
    Ai Zheng; 2002 Feb; 21(2):146-8. PubMed ID: 12479063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocellular Carcinoma Surveillance Among Cirrhotic Patients With Commercial Health Insurance.
    Goldberg DS; Valderrama A; Kamalakar R; Sansgiry SS; Babajanyan S; Lewis JD
    J Clin Gastroenterol; 2016 Mar; 50(3):258-65. PubMed ID: 26352107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased energy expenditure in cirrhotic patients with hepatocellular carcinoma.
    Merli M; Riggio O; Servi R; Zullo A; De Santis A; Attili AF; Capocaccia L
    Nutrition; 1992; 8(5):321-5. PubMed ID: 1330106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential role of circulating endothelial progenitor cells in cirrhotic patients with or without hepatocellular carcinoma.
    Sieghart W; Fellner S; Reiberger T; Ulbrich G; Ferlitsch A; Wacheck V; Peck-Radosavljevic M
    Dig Liver Dis; 2009 Dec; 41(12):902-6. PubMed ID: 19501032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A clinical study of lectin-reactive alpha-fetoprotein as an early indicator of hepatocellular carcinoma in the follow-up of cirrhotic patients.
    Shiraki K; Takase K; Tameda Y; Hamada M; Kosaka Y; Nakano T
    Hepatology; 1995 Sep; 22(3):802-7. PubMed ID: 7544756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-hepatectomy Refractory Ascites in Cirrhotic Patients with Hepatocellular Carcinoma: Risk Factor Analysis to Overcome this Problematic Complication.
    Itoh S; Uchiyama H; Ikeda Y; Morita K; Harada N; Sugimachi K; Kawanaka H; Korenaga D; Yoshizumi T; Takenaka K; Maehara Y
    Anticancer Res; 2017 Mar; 37(3):1381-1385. PubMed ID: 28314307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct-acting antiviral therapy decreases hepatocellular carcinoma recurrence rate in cirrhotic patients with chronic hepatitis C.
    Virlogeux V; Pradat P; Hartig-Lavie K; Bailly F; Maynard M; Ouziel G; Poinsot D; Lebossé F; Ecochard M; Radenne S; Benmakhlouf S; Koffi J; Lack P; Scholtes C; Uhres AC; Ducerf C; Mabrut JY; Rode A; Levrero M; Combet C; Merle P; Zoulim F
    Liver Int; 2017 Aug; 37(8):1122-1127. PubMed ID: 28423231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The validation of the 2010 American Association for the Study of Liver Diseases guideline for the diagnosis of hepatocellular carcinoma in an endemic area.
    Lin MT; Chang KC; Chou YP; Tseng PL; Yen YH; Wang CC; Tsai MC; Cheng YF; Eng HL; Wu CK; Hu TH
    J Gastroenterol Hepatol; 2015 Feb; 30(2):345-51. PubMed ID: 25092265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glutaminase and glutamine synthetase activities in human cirrhotic liver and hepatocellular carcinoma.
    Matsuno T; Goto I
    Cancer Res; 1992 Mar; 52(5):1192-4. PubMed ID: 1346587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.